[1]刘毅力,郭 冲,尹 恒,等.环状RNA circ-TAGLN在卵巢癌细胞中的表达及对卵巢癌细胞增殖和侵袭的影响[J].陕西医学杂志,2024,(2):147-151.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.001]
 LIU Yili,GUO Chong,YIN Heng,et al.Expression of circular RNA circ-TAGLN in ovarian cancer and its effect on ovarian cancer cell proiferation and invasion[J].,2024,(2):147-151.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.001]
点击复制

环状RNA circ-TAGLN在卵巢癌细胞中的表达及对卵巢癌细胞增殖和侵袭的影响
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年2期
页码:
147-151
栏目:
基础研究
出版日期:
2024-02-05

文章信息/Info

Title:
Expression of circular RNA circ-TAGLN in ovarian cancer and its effect on ovarian cancer cell proiferation and invasion
作者:
刘毅力1郭 冲1尹 恒1刘 洋2
(1.湖北医药学院附属太和医院妇产中心,湖北 十堰 442000; 2.昆明医科大学第一附属医院肿瘤科,云南 昆明 650032)
Author(s):
LIU YiliGUO ChongYIN HengLIU Yang
(Obstetrics and Gynecology Center,Taihe Hospital Affiliated to Hubei Medical College,Shiyan 442000,China)
关键词:
卵巢肿瘤 circ-TAGLN miR-425-5p 细胞增殖 细胞侵袭 分子机制
Keywords:
Ovarian tumor circ-TAGLN miR-425-5p Cell proliferation Cell invasion Molecular mechanism
分类号:
R 737.31
DOI:
DOI:10.3969/j.issn.1000-7377.2024.02.001
文献标志码:
A
摘要:
目的:探讨环状RNA(circRNA)circ-TAGLN在卵巢癌细胞中的表达情况和过表达circ-TAGLN对卵巢癌细胞增殖和侵袭的影响及分子机制。方法:采用实时荧光定量聚合酶链反应(RT-qPCR)技术分析circ-TAGLN在卵巢癌细胞系SK-OV-3、OC3、Caov-3、A2780、HO-8910和正常卵巢上皮细胞IOSE80中的表达差异。分别转染pcDNA3.1对照质粒(NC组)和pcDNA3.1-circ-TAGLN质粒(circ-TAGLN组)至SK-OV-3细胞。利用平板克隆实验和Transwell实验检测卵巢癌SK-OV-3细胞的增殖和侵袭能力。双荧光素酶报告实验验证circ-TAGLN与miR-425-5p的靶向关系。利用RT-qPCR技术分析过表达circ-TAGLN对SK-OV-3细胞中miR-425-5p表达的影响。Western blot检测过表达circ-TAGLN对SK-OV-3细胞中PI3K/AKT信号通路蛋白p-PI3K、p-AKT、p-mTOR、VEGF、eNOS表达的影响。结果:与IOSE80细胞相比,circ-TAGLN在卵巢癌细胞系SK-OV-3、OC3、Caov-3、A2780、HO-8910中低表达(均P<0.05)。NC组与circ-TAGLN组中circ-TAGLN相对表达分别为(1.01±0.34)和(7.56±1.07),circ-TAGLN组SK-OV-3细胞中circ-TAGLN表达高于NC组(P<0.01)。在SK-OV-3细胞中,过表达circ-TAGLN后细胞增殖能力和侵袭能力均下降(均P<0.01)。circ-TAGLN靶向结合miR-425-5p(P<0.01)。NC组与circ-TAGLN组SK-OV-3细胞中miR-425-5p表达分别为(5.57±0.91)和(1.01±0.17),与NC组相比,过表达circ-TAGLN后SK-OV-3细胞中miR-425-5p表达被抑制(P<0.01)。在SK-OV-3细胞中,过表达circ-TAGLN后细胞中PI3K/AKT信号通路蛋白p-PI3K、p-AKT、p-mTOR、VEGF、eNOS表达下降(均P<0.01)。结论:circ-TAGLN在卵巢癌细胞中低表达,并能通过靶向降低miR-425-5p表达抑制卵巢癌细胞的增殖和侵袭,circ-TAGLN可作为卵巢癌潜在的分子治疗靶点。
Abstract:
Objective:To explore the expression of circular RNA(circRNA)circ-TAGLN in ovarian cancer and the effects and molecular mechanisms of overexpression of circ-TAGLN on the proliferation and invasion of ovarian cancer cells.Methods:RT-qPCR was used to analyze the expression differences of circ-TAGLN in ovarian cancer cell lines SK-OV-3,OC3,Caov-3,A2780,HO-8910 and normal ovarian epithelial cells IOSE80.The pcDNA3.1 control plasmid(NC group)and pcDNA3.1-circ-TAGLN plasmid(circ-TAGLN group)were transfected into SK-OV-3 cells respectively.The proliferation and invasion abilities of ovarian cancer SK-OV-3 cells were detected using plate cloning assay and Transwell assay.Dual-luciferase reporter experiment verified the targeting relationship between circ-TAGLN and miR-425-5p.The effect of overexpression of circ-TAGLN on the expression of miR-425-5p in SK-OV-3 cells was analyzed using RT-qPCR.Western blot was used to detect the effect of overexpression of circ-TAGLN on the expression of PI3K/AKT signaling pathway proteins p-PI3K,p-AKT,p-mTOR,VEGF,and eNOS in SK-OV-3 cells.Results:Compared with IOSE80 cells,circ-TAGLN was lowerly expressed in ovarian cancer cell lines SK-OV-3,OC3,Caov-3,A2780,and HO-8910(all P<0.05).The relative expressions of circ-TAGLN in the NC group and circ-TAGLN group were(1.01±0.34)and(7.56±1.07)respectively,and the expression of circ-TAGLN in SK-OV-3 cells in the circ-TAGLN group was higher than that in the NC group(P<0.01).In SK-OV-3 cells,overexpression of circ-TAGLN reduced cell proliferation and invasion abilities(both P<0.01).circ-TAGLN targeted and binded to miR-425-5p.The expression of miR-425-5p in SK-OV-3 cells in the NC group and circ-TAGLN group were(5.57±0.91)and(1.01±0.17)respectively.Compared with the NC group,the expression of miR-425-5p in SK-OV-3 was inhibited(P<0.01).In SK-OV-3 cells,overexpression of circ-TAGLN reduced the expression of PI3K/AKT signaling pathway proteins p-PI3K,p-AKT,p-mTOR,VEGF,and eNOS in the cells.Conclusion:circ-TAGLN is lowly expressed in ovarian cancer and can inhibit the proliferation and invasion of ovarian cancer cells by targeting the reduction of miR-425-5p expression.circ-TAGLN can be used as a potential molecular therapeutic target for ovarian cancer.

参考文献/References:

[1] RICHARDSON D L,ESKANDER R N,MALLEY D M.Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance:A narrative review[J].JAMA Oncol,2023,9(6):851-859.
[2] SMITH M,POTHURI B.Appropriate selection of PARP inhibitors in ovarian cancer[J].Curr Treat Options Oncol,2022,23(6):887-903.
[3] 许静,李霞.化瘀利水方联合腹腔热灌注化疗治疗原发性卵巢癌伴癌性腹水疗效观察[J].陕西中医,2023,44(9):1202-1204.
[4] MA L,LIU W,LI M.circ-0061140 contributes to ovarian cancer progression by targeting miR-761/LETM1 signaling[J].Biochem Genet,2023,61(2):628-650.
[5] 陈隆,张玉富.胶质瘤中circular RNA PRKCI的表达及预后相关影响因素研究[J].陕西医学杂志,2021,50(11):1449-1451.
[6] WANG H,ZHANG X,QIAO L,et al.circRNA circ-0000554 promotes ovarian cancer invasion and proliferation by regulating miR-567[J].Environ Sci Pollut Res Int,2022,29(13):19072-19080.
[7] NAJAFI S.The emerging roles and potential applications of circular RNAs in ovarian cancer:A comprehensive review[J].J Cancer Res Clin Oncol,2023,149(5):2211-2234.
[8] 刘少璇,李佳,刘芳媛,等.基于“亢害承制”理论辨析卵巢癌因机证治[J].陕西中医,2022,43(7):925-928.
[9] 徐梓凡,郑昊涵,谢田华,等.环状RNA功能及与眼科相关疾病关系研究进展[J].陕西医学杂志,2023,52(5):626-629.
[10] FU L,ZHANG D,YI N,et al.circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression [J].Hum Cell,2022,35(5):1560-1576.
[11] ZHENG Y,LI Z,YANG S,et al.circEXOC6B suppresses the proliferation and motility and sensitizes ovarian cancer cells to paclitaxel through miR-376c-3p/FOXO3 axis[J].Cancer Biother Radiopharm,2022,37(9):802-814.
[12] SUN N,LIU S,CHEN A.Diagnostic value of non-coding RNAs in ovarian cancer[J].J Obstet Gynaecol,2022,42(8):3416-3423.
[13] HUANG C,QIN L,CHEN S,et al.circSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression[J].Anticancer Drugs,2023,34(3):395-404.
[14] LI X,JIANG X,LU J,et al.circCERS6 suppresses the development of epithelial ovarian cancer through mediating miR-630/RASSF8[J].Biochem Genet,2022,60(6):2611-2629.
[15] HUANG X,LUO Y,LI X.circ-0072995 promotes ovarian cancer progression through regulating miR-122-5p/SLC1A5 axis[J].Biochem Genet,2022,60(1):153-172.
[16] YING H,ZHAO R,YU Q,et al.circATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis[J].Drug Dev Res,2022,83(2):512-524.
[17] WU Y,ZHOU J,LI Y,et al.Hsa-circ-0001445 works as a cancer suppressor via miR-576-5p/SFRP1 axis regulation in ovarian cancer[J].Cancer Med,2023,12(5):5736-5750.
[18] FU Y,LI Y,WANG X,et al.Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer[J].Cancer Biomark,2020,27(2):147-156.
[19] LIU D,ZHANG H,CUI M,et al.Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-catenin pathway and EMT in colorectal cancer[J].Cell Cycle,2020,19(15):1917-1927.
[20] ZHANG L F,ZHANG J G,ZHOU H,et al.microRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling[J].Kaohsiung J Med Sci,2020,36(4):250-256.
[21] ZHAO Y,YUAN D,ZHU D,et al.lncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p[J].J Ovarian Res,2021,14(1):109.
[22] BI X,LV X,LIU D,et al.METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway[J].Cancer Gene Ther,2021,28(3-4):335-349.
[23] WU Z,GUO J,ZHANG Y,et al.miR-425-5p accelerated the proliferation,migration,and invasion of ovarian cancer cells via targeting AFF4[J].J Ovarian Res,2021,14(1): 138.
[24] XIAO S,ZHU H,LUO J,et al.miR-425-5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN[J].Oncol Rep,2019,42(6): 2550-2560.
[25] ZHOU J S,YANG Z S,CHENG S Y,et al.miRNA-425-5p enhances lung cancer growth via the PTEN/PI3K/AKT signaling axis[J].BMC Pulm Med,2020,20(1): 223.

相似文献/References:

[1]史阿娉,史成兴,杨志军,等.超声造影与彩色多普勒超声检查诊断卵巢肿瘤对比研究*[J].陕西医学杂志,2019,(5):628.
 SHI Aping,SHI Chengxing,YANG Zhijun,et al.Comparative analysis of contrastenhanced ultrasound and color doppler ultrasound in the identification of ovarian tumors[J].,2019,(2):628.
[2]杨 勇,王 冰△.人绒毛膜促性腺激素、人附睾蛋白4、糖类抗原199联合检测对卵巢肿瘤的诊断价值[J].陕西医学杂志,2019,(8):1091.
 YANG Yong,WANG Bing..The diagnostic value of β-HCG,HE4, CA199 joint detection for ovarian neoplasms[J].,2019,(2):1091.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81860515)
更新日期/Last Update: 2024-02-05